Denmark-based Bavarian Nordic https://www.reuters.com/markets/companies/BAVA.CO” target=”_blank” rel=”noopener”>(BAVA.CO) said on Saturday it was ending its respiratory syncytial virus (RSV) vaccine programme as its Phase 3 clinical trial did not meet all the p…
Read More
About The Author
